CytoMed Therapeutics (GDTC) Intangibles (2021 - 2025)
CytoMed Therapeutics (GDTC) posted Intangibles of $96365.5 for Q4 2025, up 32.82% sequentially from $72556.0 in Q2 2025, and up 37.76% YoY from $69952.8 in Q4 2024.
CytoMed Therapeutics (GDTC) Intangibles (2021 - 2025) Analysis & Trends
CytoMed Therapeutics has reported Intangibles for 5 years, with the latest figure at $96365.5 in Q4 2025.
- Quarterly Intangibles rose 37.76% year-over-year to $96365.5 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $96365.5 (up 37.76% YoY) and the FY2025 annual result came in at $97126.0, up 39.43% from the prior year.
- Intangibles advanced to $96365.5 in Q4 2025 per GDTC's latest filing, from $72556.0 in the prior quarter.
- Over five years, Intangibles peaked at $96365.5 in Q4 2025 and troughed at $5627.0 in Q4 2023.
- A 5-year average of $41777.3 and a median of $32445.1 in 2021 frame the typical range for Intangibles.
- The sharpest annual moves came in 2023 and 2024: Intangibles tumbled 84.36% in 2023, then surged 1143.15% in 2024.
- Over 5 years, Intangibles stood at $28910.4 in 2021, then advanced by 24.45% to $35979.8 in 2022, then sank by 84.36% to $5627.0 in 2023, then soared by 1143.15% to $69952.8 in 2024, then soared by 37.76% to $96365.5 in 2025.
- According to Business Quant data, Intangibles over the past three periods registered $96365.5, $72556.0, and $69952.8 for Q4 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 266.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 60.96 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 93.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | CytoMed Therapeutics | 10.72 Mn | 9.11 Mn | - | 96,365.46 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 96,365.46 |
| Jun 30, 2025 | 72,556.00 |
| Dec 31, 2024 | 69,952.80 |
| Jun 30, 2024 | 11,012.00 |
| Dec 31, 2023 | 5,627.04 |
| Jun 30, 2023 | 13,815.00 |
| Dec 31, 2022 | 35,979.82 |
| Dec 31, 2021 | 28,910.37 |